Understanding low blood counts with bone marrow testing
Part of Blood & lymphatic clinical trials.
This study looks at the causes of pancytopenia, a condition where all three types of blood cells (red, white, and platelets) are lower than normal. By doing blood tests and a bone marrow biopsy, doctors hope to better understand what is causing it and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- All three types of blood cells are below normal: red blood cells, white blood cells, and platelets.
- You are willing to have a bone marrow biopsy, a procedure that takes a small sample from inside your bone.
- You have not refused to take part in this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tries to see if blood tests can replace a bone marrow biopsy for people with low blood counts (cytopenia) and suspected MDS (myelodysplastic syndrome). It aims to make diagnosis less invasive by using a simple blood draw instead of a bone marrow sample.
This study follows people with ongoing low blood counts (red cells, white cells, and/or platelets) to better understand their condition when it does not meet criteria for MDS. It may help improve how persistent blood count problems are evaluated over time.
This study follows people who may have early, unclear blood count problems or certain genetic/immune patterns that can later lead to bone marrow failure or blood cancers. It may help doctors better understand risks over time and guide earlier care.
This trial tests how well platelet transfusions work for patients with blood cancers or bone marrow failure who have very low platelets and need a transfusion. It aims to see if the transfusions help control bleeding and improve outcomes.
This trial looks at how common a harmless condition called ethnic neutropenia (low white blood cells) and a specific blood type (Duffy null) are in newborns at Kaplan Medical Center. It helps doctors understand normal blood cell differences across ethnic groups.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
Hear when a new Pancytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.